Reports
Sale
Global Small Scale Bioreactors Market Size, Trends, Report: By Product: Reusable Bioreactors, Single Use Bioreactors; By Capacity: 5 mL-100 mL, 100 mL – 250 mL, 250 mL – 500 mL, 500 mL – 1 L, 1 L – 3 L, 3 L – 5 L; By Cells: Bacterial Cells, Yeast Cells, Mammalian Cells; By End User; Regional Analysis; Competitive Landscape; 2024-2032
Global Small Scale Bioreactors Market Outlook
The global small scale bioreactors market size was valued at USD 2 billion in 2023, driven by the increasing prevalence of chronic diseases such as cancer across the globe. The market size is anticipated to grow at a CAGR of 14.3% during the forecast period of 2024-2032 to achieve a value of USD 6.7 billion by 2032.
Small Scale Bioreactors: Introduction
Small scale bioreactors are containers specialized to be used for cultivating microorganisms or living cells under accurately controlled conditions, facilitating the production of various molecules. These bioreactors are particularly valuable as essential tools for process development and optimization in pharmaceutical and biopharmaceutical studies. Typically designed for smaller-scale production, they come in a range of sizes, spanning from a few millilitres to 5-10 litres. Notably, small scale bioreactors offer economic advantages, requiring less labour than their larger counterparts.
These bioreactors are often employed as cost-effective miniaturized alternatives that effectively replicate almost all the functional capabilities of bench-scale reactors at significantly reduced volumes. Small Scale bioreactors have the capability for parallel operation enabling a cost-efficient series of experiments to be conducted. A few examples of small scale bioreactors include shake flasks, microtiter plates, and benchtop bioreactors. Additionally, small scale bioreactors come in both reusable and single-use variants, with the latter employing disposable bags in lieu of traditional reusable steel vessels.
Global Small Scale Bioreactors Market Analysis
The global market for small scale bioreactors is witnessing notable trends that are shaping its trajectory in recent years and are expected to continue in the forecast period. One significant trend is the substantial surge in sales of small scale bioreactors in 2020 and 2021, primarily driven by numerous businesses expanding their facilities to conduct crucial research and development for COVID-19 vaccines. This heightened demand for bioprocessing equipment played a pivotal role in the market's growth. Furthermore, with ongoing global immunization campaigns and the persistent demand for vaccines, the sales of small scale bioreactors are expected to maintain their upward trajectory.
Government authorities have also made substantial investments in enhancing biopharmaceutical research and expediting vaccine development, further influencing the Small Scale bioreactors market growth. These investments are geared towards advancing the capabilities of bioprocessing equipment, including small scale bioreactors, to meet the increasing demands for vaccine production and other biopharmaceutical research needs. As a result, the small scale bioreactors market is expected to continue to thrive, driven by these trends that underscore the critical role of bioprocessing in addressing global healthcare challenges.
Global Small Scale Bioreactors Market Segmentations
Market Breakup by Product
- Reusable Bioreactors
- Stainless Steel Bioreactors
- Glass Bioreactors
- Single-Use Bioreactors
Market Breakup by Capacity
- 5 mL-100 mL
- 100 mL – 250 mL
- 250 mL – 500 mL
- 500 mL – 1 L
- 1 L – 3 L
- 3 L – 5 L
Market Breakup by Cells
- Bacterial Cells
- Yeast Cells
- Mammalian Cells
Market Breakup by End User
- Pharmaceutical and Biopharmaceutical Companies
- CROs and CMOs
- Academic and Research Institutes
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Small Scale Bioreactors Market Overview
The global market for small scale bioreactors is experiencing robust growth driven by key factors such as the widespread utilization of small scale bioreactors in the pharmaceutical industry, coupled with the expansion of product portfolios by key players, which has significantly contributed to market expansion. These bioprocessing tools play a crucial role in the development and optimization of processes, making them invaluable in pharmaceutical and biopharmaceutical research. Small scale bioreactors typically range in size from a few millilitres to 5-10 litres and are essential for small scale production.
The increasing prevalence of chronic diseases such as cancer, cardiac disease, diabetes, and hypertension has also driven the development of innovative biological therapies, contributing to the increased demand for small scale bioreactors, particularly for producing monoclonal antibodies and personalized medicines. The adoption of advanced technologies to streamline complex manufacturing processes is also boosting the demand for Small Scale bioreactors in the biopharmaceutical sector, further propelling the small scale bioreactors market growth.
Moreover, significant investments in research and development activities by key biopharmaceutical companies are expected to further propel industry growth. The rising investments in biopharmaceutical research, driven by the growing incidence of chronic diseases and the demand for novel biologic drugs, coupled with the adoption of advanced bioprocessing equipment like small scale bioreactors, are some of the key drivers fuelling the growth of the market.
Global Small Scale Bioreactors Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Sartorius AG
- Merck KGaA
- Lonza Group
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Getinge AB
- Eppendorf AG
- Miltenyi Biotec
- Solaris Biotechnology Srl
- Infors AG
- H.E.L Group
- Lianyungang Bailun Biochemical Technology Co., Ltd
- Cytiva
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Capacity |
|
| Breakup by Cells |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Small Scale Bioreactors Market Overview
3.1 Global Small Scale Bioreactors Market Historical Value (2017-2023)
3.2 Global Small Scale Bioreactors Market Forecast Value (2024-2032)
4 Global Small Scale Bioreactors Market Landscape
4.1 Global Small Scale Bioreactors Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Small Scale Bioreactors Product Landscape
4.2.1 Analysis by Type of Biosensor
4.2.2 Analysis by Technology Used
4.2.3 Analysis by Applications
5 Global Small Scale Bioreactors Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Small Scale Bioreactors Market Segmentation
6.1 Global Small Scale Bioreactors Market by Product
6.1.1 Market Overview
6.1.2 Reusable Bioreactors
6.1.2.1 Stainless Steel Bioreactors
6.1.2.2 Glass Bioreactors
6.1.3 Single Use Bioreactors
6.2 Global Small Scale Bioreactors Market by Capacity
6.2.1 Market Overview
6.2.2 5 mL-100 mL
6.2.3 100 mL – 250 mL
6.2.4 250 mL – 500 mL
6.2.5 500 mL – 1 L
6.2.6 1 L – 3 L
6.2.7 3 L – 5 L
6.3 Global Small Scale Bioreactors Market by Cells
6.3.1 Market Overview
6.3.2 Bacterial Cells
6.3.3 Yeast Cells
6.3.4 Mammalian Cells
6.4 Global Small Scale Bioreactors Market by End User
6.4.1 Market Overview
6.4.2 Pharmaceutical and Biopharmaceutical Companies
6.4.3 CROs and CMOs
6.4.4 Academic and Research Institutes
6.4.5 Others
6.5 Global Small Scale Bioreactors Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Small Scale Bioreactors Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Small Scale Bioreactors Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Small Scale Bioreactors Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Small Scale Bioreactors Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Small Scale Bioreactors Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Sartorius AG
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Merck KGaA
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Lonza Group
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Thermo Fisher Scientific Inc.
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Danaher Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Getinge AB
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Eppendorf AG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Miltenyi Biotec
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Solaris Biotechnology Srl
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Infors AG
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 H.E.L Group
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Lianyungang Bailun Biochemical Technology Co., Ltd
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Cytiva
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Small Scale Bioreactors Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 2 billion in 2023, driven by increasing research activities.
The market is anticipated to grow at a CAGR of 14.3% during the forecast period of 2024-2032 and is likely to reach a market value of USD 6.7 billion by 2032.
The expanded application of small scale bioreactors in the pharmaceutical industries is a major factor driving the market growth.
The surging demand for small scale bioreactors in the market for the purpose of research and development is a major trend influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Various products in the market include reusable and single-use bioreactors.
Small scale bioreactors are available in 5 mL-100 mL, 100 mL – 250 mL, 250 mL – 500 mL, 500 mL – 1 L, 1 L – 3 L, and 3 L – 5 L.
Bacterial cells, yeast cells, and mammalian cells are processed in these bioreactors.
End users in the market are pharmaceutical and biopharmaceutical companies, CROs and CMOs, academic and research institutes, among others.
Key players involved in the market are Sartorius AG, Merck KGaA, Lonza Group, Thermo Fisher Scientific Inc., Danaher Corporation, Getinge AB, Eppendorf AG, Miltenyi Biotec, Solaris Biotechnology Srl, Infors AG, H.E.L Group, Lianyungang Bailun Biochemical Technology Co., Ltd, and Cytiva.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER